Searched for
BAYER ZYDUS PHARMA
Bayer bets big on 'self-care' market to deepen India playGlobal pharma major Bayer is significantly expanding its consumer healthcare presence in India, targeting the burgeoning self-care market e...- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Amfi stock classification: Multibaggers BHEL, NHPC, 5 more stocks to likely turn largecapsIn the upcoming Amfi Semi-Annual Categorisation for the second half of 2024, seven stocks, including Hero MotoCorp and BHEL, are poised to ...
- Bayer acquires remaining 25% stake in Bayer Zydus Pharma Pvt Ltd to secure full ownershipBayer Pharmaceuticals Private Limited and Zydus Lifesciences Limited have concluded their joint venture, Bayer Zydus Pharma Private Limited...
- MNC pharma body OPPI appoints Anil Matai as new director generalThe Organisation of Pharmaceutical Producers of India (OPPI) has appointed Anil Matai as its director general. Matai has extensive experien...
- Q1 results this week: LIC, Adani Ports, IRCTC, Hero MotoCorp, Nykaa and othersAdani Ports, Coal India, Siemens, Hindalco, Linde India, Lloyds Metals, Phoenix Mills, Oil India, Prestige Estates, Aarti Industries, Happi...
- Bayer launches pill to treat chronic kidney disease linked to diabetesThe drug, touted as a potential blockbuster drug for the German pharmaceutical firm, will be sold under the brand name Kerendia in India.
- Bayer introduces medication for chronic kidney disease"The major focus of therapy in patients with chronic kidney disease and diabetes is to prevent end-stage renal disease or kidney failure. D...
- Cadila, Bayer extend JV partnership for three years"The spirit of partnership in this joint venture has all been about channelling the core strengths of both Zydus and Bayer for the benefit ...
- Bayer's Aflibercept injection gets DCGI nod for Diabetic Macular Edema indicationDiabetic Macular Edema occurs when high blood sugar levels damage capillaries that leak fluid into the retina, resulting in swelling and bl...
- Bayer Pharmaceuticals committed to India growth; to push for more R&D"Asia Pacific is the fastest growing region for Bayer's pharmaceuticals sales globally. We are very interested and committed to India and a...
- Bayer CropScience appoints Pankaj Patel as chairmanBayer CropScience informed that the board appointed Pankaj Patel as an additional non-executive director of the company with effect from Ju...
- Delhi HC turns down Bayer plea on stroke drug against Dr Reddy'sIn India, Bayer sells the product through its equal stake JV Bayer Zydus, formed with Ahmedabad-based Zydus Cadila.
- Zydus to invest Rs 100 crore in Vadodara unit, expand hospital businessZydus Hospitals & Healthcare Research recently started its first hospital operations at Anand, better known as Amul's hometown.
- Zydus Cadila buys out Biochem PharmaceuticalsZydus Cadila has acquired 100% stake in Mumbai-based Biochem Pharmaceuticals for an undisclosed amount.
- Bayer AG expects India sales to double by 2015Bayer AG said it expects sales in India to double by 2015 and targets more than 60% increase in revenue from entire Asia during the period
- Zydus Cadila Q1 net up 15.38% at Rs 229.82 croreAhmedabad-based Zydus Cadila today said its consolidated net profit rose by 15.38 per cent to Rs 229.82 crore in the first quarter ended Ju...
- Cadila Healthcare Q4 net zooms by 50.69 pc to Rs 178.97 crCadila Healthcare today said its consolidated net profit rose by 50.69 per cent to Rs 178.97 crore for the fourth quarter ended March 31, 2...
- Cadila Healthcare forms JV with BayerCadila Healthcare has signed an agreement with Bayer HealthCare to set up 50:50 joint venture in the name of "Bayer Zydus Pharma" for the s...
- Zydus Cadila in talks to market Bayer drugsAhmedabad-based drugmaker Zydus Cadila is in talks with Bayer Schering Pharma AG to market the German firm’s products in Indian retail mark...
Load More
